Volume 12, Issue 2 , Pages 62-66, April 2010
Screening for Barrett's esophagus
Barrett's esophagus (BE) increases the risk for development of esophageal adenocarcinoma. Because of the rapid rise in incidence of esophageal adenocarcinoma, screening for BE with subsequent surveillance when found has been proposed as a method of early detection. Sedated endoscopy, however, is too expensive for widespread screening. As a result, other techniques, including unsedated transnasal esophagoscopy and capsule esophagoscopy, have been proposed to expand screening programs.
Keywords: Barrett's esophagus, Screening, Unsedated, Capsule, Cost, Esophageal adenocarcinoma
To access this article, please choose from the options below
The authors have no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.
The illustration for Figure 1 of this manuscript was redrawn by Jason LeVasseur, applied art studio (www.appliedartstudio.com).
PII: S1096-2883(10)00020-3
doi:10.1016/j.tgie.2010.02.009
© 2010 Elsevier Inc. All rights reserved.
Volume 12, Issue 2 , Pages 62-66, April 2010
